AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.300
+0.240 (22.64%)
Nov 20, 2024, 4:00 PM EST - Market closed
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $38.80 million as of November 21, 2024. Its market cap has decreased by -91.73% in one year.
Market Cap
38.80M
Enterprise Value
-54.63M
1-Year Change
-91.73%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $38.80M, a decrease of -86.20%. That is a compound annual growth rate of -52.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 31.63M | -94.81% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioVie | 30.69M |
| KALA BIO | 30.68M |
| SAB Biotherapeutics | 30.66M |
| DURECT | 30.08M |
| OneMedNet | 29.98M |
| IceCure Medical | 29.71M |
| IRIDEX | 29.05M |
| Passage Bio | 28.98M |